ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

Monroe Wall, Co-Discoverer Of Taxol, Camptothecin, Dead At 85

July 12, 2002

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Chemoprevention Clinical Trials To starts In 1982 If Greenwald, DRCCA Board Can Move Fast Enough

August 28, 1981

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

May 30, 1980

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

October 25, 2013